Skip to content
Home » Resources » Personalised Medicine: What Does It Mean for Cancer Patients in Europe? – Biomarkers Guide

Personalised Medicine: What Does It Mean for Cancer Patients in Europe? – Biomarkers Guide

    Personalised Medicine: What Does It Mean for Cancer Patients in Europe? – Biomarkers Guide

    Publication format: Toolkit
    Year: 2025
    Topic: Research & Innovation
    Language: English
    View this resource

    This patient-facing toolkit provides a comprehensive introduction to personalised medicine in cancer care, explaining how genomic testing and biomarker analysis enable treatment tailored to individual tumor biology. Structured as an educational guide for newly diagnosed cancer patients, it demystifies key concepts including genomic profiling, companion diagnostics, targeted therapies, and immunotherapy selection. The booklet addresses practical patient concerns: what genomic testing involves, when it should be requested, how to discuss it with oncologists, understanding test results, and navigating access barriers across EU healthcare systems. Includes a glossary of technical terms, decision-making flowcharts, and resources for further information. Designed to empower patients to advocate for precision medicine approaches in their own care.